美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,369.82

+5.130.38%

涨家数：10

跌家数：10

平家数：- -

市盈率：- -

高：1,380.29

开：1,364.76

低：1,358.78

收：1,364.65

数据加载中...

Co-Diagnostics, Inc.盘中异动早盘快速下挫7.57%报0.331美元

阿斯利康涉嫌未缴纳进口税，在华或面临800万美元新罚款，一季度中国市场业绩增长小于整体新兴市场

减肥药“断腕”、核心药物承压辉瑞（PFE.US）欲“买买买”加码心脏代谢短板

减肥药“断腕”、核心药物承压辉瑞欲“买买买”加码心脏代谢短板

【洞察】达格列净二甲双胍缓释片属于口服降糖复方制剂我国市场竞争在不断加剧

Ofweek维科网

阿斯利康中国区一季度收入增5% 或面临最高800万美元新罚单

阿斯利康公布中国调查最新进展

阿斯利康回应在中国面临最新罚款

阿斯利康再披露中国区涉嫌走私及侵犯公民信息案件进展

辉瑞4月29日成交额为23.31亿美元

21健讯Daily | 接棒吴以芳，陈玉卿出任复星医药董事长；阿斯利康一季度收入135.88亿美元

21世纪经济报道

阿斯利康在华面临800万美元新罚款？公司回应了

21世纪经济报道

阿斯利康4月29日成交额为5.64亿美元

雅培4月29日成交额为5.63亿美元

【吉利德科学与美国政府达成2亿美元和解协议】吉利德科学与美国政府达成2.02亿美元的和解协议，以解决其向医生支付费用并为他们提供活动餐费和差旅费以让其开出其药物的指控。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。该等活动原本纯粹是为了教育目的，并提供简单的餐点，但该公司在高档餐厅举办活动。检察官称，许多医生随后开出该公司的药物，迫使联邦医疗保健计划为该等处方支付数百万美元的报销费用。

阿斯利康在中国或面临800万美元新罚款，涉及乳腺癌药物

多款 FIC 生物新药首发 AACR ！来自阿斯利康、GSK、信达...

Insight数据库

阿斯利康在中国或面临800万美元新罚款，涉及乳腺癌药物

吉利德科学公司在美国就艾滋病药物回扣问题达成和解，将支付 2.02 亿美元

阿斯利康盘中异动下午盘股价大涨3.02%报72.05美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1369.7783,"timestamp":1746035869040,"preClose":1364.6454,"halted":0,"volume":55209837,"delay":0,"changeRate":0.003761,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":5.132935,"latestTime":"04-30 13:57:49 EDT","open":1364.7573,"high":1380.285,"low":1358.7754,"amount":2309317810.54055,"amplitude":0.015762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.640146,"peRate":22.008402,"turnoverRate":0.00356,"increases":10,"decrements":10,"flats":0,"marketCap":1131251107104,"floatMarketCap":1111407232306},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1380.285,"amplitude":0.015762,"preClose":1364.6454,"low":1358.7754,"pbRate":"3.640146","latestPrice":1369.8214,"volume":55192632,"delay":0,"open":1364.7573,"prevYearClose":1274.8187,"prevWeekClose":1341.1263,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1344.1606,"twentyDayClose":1377.6108,"sixtyDayClose":1350.7439,"secType":"PLATE","market":"US","turnoverRate":0.00356,"peRate":22.008402,"marketCap":1131279451424,"floatMarketCap":1111435535666,"timestamp":1746035863542,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":10,"down":10,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531809053","title":"Co-Diagnostics, Inc.盘中异动 早盘快速下挫7.57%报0.331美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531809053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531809053?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 21:38","pubTimestamp":1746020287,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时38分，Co-Diagnostics, Inc.股票出现异动，股价快速跳水7.57%。截至发稿，该股报0.331美元/股，成交量6060股，换手率0.02%，振幅4.19%。Co-Diagnostics, Inc.股票所在的医疗器械行业中，整体跌幅为0.32%。其相关个股中，Invo Fertility, Inc.、Sintx Technologies, Inc.、Smith & Nephew Plc涨幅较大，Invo Fertility, Inc.、Autonomix Medical, Inc.、Bluejay Diagnostics, Inc.较为活跃，换手率分别为3642.53%、48.88%、3.90%，振幅较大的相关个股有Invo Fertility, Inc.、Autonomix Medical, Inc.、Nortech Systems Incorporated，振幅分别为37.25%、11.46%、10.92%。Co-Diagnostics, Inc.公司简介：Co-Diagnostics Inc是一家分子诊断公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213807a46dc7f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213807a46dc7f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2531703130","title":"阿斯利康涉嫌未缴纳进口税，在华或面临800万美元新罚款，一季度中国市场业绩增长小于整体新兴市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2531703130","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531703130?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 15:24","pubTimestamp":1745997883,"startTime":"0","endTime":"0","summary":"蓝鲸新闻4月30日讯 阿斯利康可能会在中国面临一项新的罚款，金额或达800万美元。英国当地时间4月29日，阿斯利康公布2025年一季报，其中单独对中国市场“2025年4月，与中国调查有关的事态发展”做出了详细描述。意见书显示阿斯利康涉嫌偷逃进口税款，金额达160余万美元。若阿斯利康被最终判定需承担法律责任，可能被处以未缴进口税款一至五倍的罚金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/256427","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU1829250122.USD","LU0109394709.USD","LU0320765992.SGD","BK4568","BK4614","LU0889565916.HKD","BK4007","LU2236285917.USD","AZN","LU2462157665.USD","LU2417539215.USD","YINN","BK4585","BK4588","LU2456880835.USD"],"gpt_icon":0},{"id":"2531774147","title":"减肥药“断腕”、核心药物承压  辉瑞（PFE.US）欲“买买买”加码心脏代谢短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531774147","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531774147?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 14:57","pubTimestamp":1745996275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞在2025年第一季度财报中披露，继口服减肥药Danuglipron研发受挫后，公司将通过收购或合作加速布局心脏代谢领域，以弥补产品线空缺。为应对业绩波动，辉瑞升级成本管控计划：在2025年底前实现45亿美元净成本节约的基础上，进一步追加12亿美元节省目标，预计到2027年底累计节省57亿美元。据了解，4月中旬，辉瑞宣布终止GLP-1受体激动剂Danuglipron的研发。辉瑞正面临核心管线断档与成本压力的双重挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002270589.USD","LU0225284248.USD","SG9999002224.SGD","SG9999002232.USD","SG9999003800.SGD","LU0122379950.USD","LU1894683348.USD","BK4581","LU0225771236.USD","IE00B19Z3581.USD","BK4592","BK4550","LU0868494617.USD","BK4588","LU0058720904.USD","LU1057294990.SGD","IE00BLSP4452.SGD","SG9999001176.USD","BK4533","SG9999001176.SGD","LU1066051498.USD","LU0306807586.USD","PFE","IE000M9KFDE8.USD","LU0985481810.HKD","LU0289739699.SGD","LU0456855351.SGD","LU0234572021.USD","SG9999013999.USD","LU0170899867.USD","LU0321505439.SGD","LU1066053197.SGD","SG9999011175.SGD","BK4007","LU1894683264.USD","BK4568","BK4599","SGXZ57979304.SGD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0306806265.USD","LU1883839398.USD","BK4534","BK4585"],"gpt_icon":1},{"id":"2531312703","title":"减肥药“断腕”、核心药物承压辉瑞欲“买买买”加码心脏代谢短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531312703","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531312703?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 14:57","pubTimestamp":1745996220,"startTime":"0","endTime":"0","summary":"辉瑞在2025年第一季度财报中披露，由于口服减肥药Danuglipron研发受挫，公司将通过收购或合作加速布局心脏代谢领域，以弥补产品线空缺。尽管Q1营收未达预期，但调整后每股收益超预期，公司维持全年盈利指引上限。新冠产品表现不一，Paxlovid收入低于预期，而Comirnaty疫苗超出预期。核心药物如Eliquis销售额下滑。为应对业绩波动，辉瑞升级成本管控计划，预计到2027年底累计节省57亿美元。辉瑞CEO表示将通过内部研发和外部合作构建心脏代谢领域产品矩阵。分析师认为，通过收购或合作快速补充产品线是突破增长瓶颈的关键。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430150811974b363e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430150811974b363e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0306806265.USD","IE0002270589.USD","IE000M9KFDE8.USD","BK4533","LU0456855351.SGD","LU1066051498.USD","BK4581","LU1023059063.AUD","IE00BLSP4452.SGD","LU0321505868.SGD","BK4007","IE00BBT3K403.USD","LU1057294990.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4550","IE00B19Z3581.USD","LU0225771236.USD","BK4585","SG9999013999.USD","LU0868494617.USD","BK4588","LU1894683348.USD","LU1894683264.USD","PFE","SG9999002224.SGD","BK4534","BK4568","IE00BLSP4239.USD","LU0225284248.USD","LU1883839398.USD","BK4599","LU0985481810.HKD","SG9999003800.SGD","LU0170899867.USD","SG9999011175.SGD","LU0234572021.USD","BK4592","LU0058720904.USD","LU0289739699.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU0122379950.USD","SG9999001176.USD","LU0306807586.USD","SG9999001176.SGD"],"gpt_icon":0},{"id":"2531770654","title":"【洞察】达格列净二甲双胍缓释片属于口服降糖复方制剂 我国市场竞争在不断加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=2531770654","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531770654?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 14:22","pubTimestamp":1745994136,"startTime":"0","endTime":"0","summary":"达格列净二甲双胍缓释片是一种新型口服降糖复方制剂，结合了达格列净及盐酸二甲双胍缓释片两种药物作用机制。达格列净二甲双胍缓释片适用于2型糖尿病的治疗。复方制剂是口服降糖药市场新风口，近年来，我国市场规模逐年增长，达格列净二甲双胍缓释片作为新型口服降糖复方制剂，市场发展前景好。目前达格列净二甲双胍缓释片市场已吸引一大批企业布局，未来国产仿制药将逐渐侵蚀进口原研药市场份额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430142221974b299c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430142221974b299c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AZN","BK4585","LU2462157665.USD","LU1829250122.USD","BK4007","BK4588","LU0320765992.SGD","LU0889565916.HKD","LU2417539215.USD","LU2236285917.USD","LU0109394709.USD","LU2456880835.USD","BK4568"],"gpt_icon":0},{"id":"2531550777","title":"阿斯利康中国区一季度收入增5% 或面临最高800万美元新罚单","url":"https://stock-news.laohu8.com/highlight/detail?id=2531550777","media":"澎湃新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531550777?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 14:18","pubTimestamp":1745993893,"startTime":"0","endTime":"0","summary":"【阿斯利康中国区一季度收入增5% 或面临最高800万美元新罚单】当地时间4月29日，跨国药企阿斯利康在公布2025年一季报的同时，再次披露了阿斯利康中国调查事件截至2025年4月的新进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504303394375729.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504303394375729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0109394709.USD","LU2456880835.USD","BK4588","LU0320765992.SGD","BK4585","LU1829250122.USD","LU2417539215.USD","BK4568","BK4007","LU2236285917.USD","LU2462157665.USD","AZN","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531776468","title":"阿斯利康公布中国调查最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2531776468","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531776468?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 13:16","pubTimestamp":1745990160,"startTime":"0","endTime":"0","summary":"4月30日，阿斯利康向第一财经记者透露了该公司在中国接受调查的最新进展。“关于涉嫌侵犯公民个人信息一事，阿斯利康收到了来自深圳市公安局宝安分局出具的有关涉嫌侵犯公民个人信息的《案件移送审查起诉告知书》。公司得悉，就该等侵犯公民个人信息行为，公司无违法所得。”阿斯利康还称，将继续全力配合中国相关部门。（第一财经记者 钱童心）\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-04-30/doc-ineuxmqz4321629.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-30/doc-ineuxmqz4321629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0320765992.SGD","BK4588","AZN","LU2417539215.USD","LU2462157665.USD","LU0889565916.HKD","LU0109394709.USD","LU1829250122.USD","LU2456880835.USD","BK4568","LU2236285917.USD","BK4585","BK4007"],"gpt_icon":0},{"id":"2531778845","title":"阿斯利康回应在中国面临最新罚款","url":"https://stock-news.laohu8.com/highlight/detail?id=2531778845","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531778845?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 12:59","pubTimestamp":1745989179,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["AZN","LU1829250122.USD","LU2417539215.USD","LU0320765992.SGD","BK4568","LU0109394709.USD","LU2456880835.USD","LU2462157665.USD","BK4585","BK4007","LU2236285917.USD","BK4588","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531721225","title":"阿斯利康再披露中国区涉嫌走私及侵犯公民信息案件进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2531721225","media":"界面","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531721225?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 11:37","pubTimestamp":1745984220,"startTime":"0","endTime":"0","summary":"前述文件显示，阿斯利康涉嫌偷逃进口税款，金额达160余万美元。阿斯利康称，将继续全力配合中国相关部门。这是阿斯利康今年第二次发布阿斯利康中国的调查进展。今年2月初，阿斯利康在公布企业2024年度财报的同时，也对涉嫌非法进口药品一事首度作出了回应。截至目前，对于涉嫌非法进口药品以及涉嫌侵犯公民个人信息事件是否与阿斯利康全球执行副总裁、国际业务主席及中国总裁王磊被调查拘留的动态相关，阿斯利康方面依旧未直接说明。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430113748a46d1695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430113748a46d1695&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU2456880835.USD","BK4588","LU0320765992.SGD","BK4585","LU1829250122.USD","LU2417539215.USD","BK4568","BK4007","LU2236285917.USD","LU2462157665.USD","AZN","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531723794","title":"辉瑞4月29日成交额为23.31亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531723794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531723794?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 10:21","pubTimestamp":1745979667,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，辉瑞成交额为23.31亿美元，成交额较昨日增加80.85%，当日成交量为9854.02万股。辉瑞于2025年4月29日涨3.21%，报23.79美元，该股过去5个交易日涨5.59%，年初至今跌8.84%，过去60日跌10.29%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|23.31亿|80.85%|9854.02万|#|2025-04-28|12.89亿|57.16%|5588.89万|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102116a46d0133&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430102116a46d0133&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU0985481810.HKD","LU1066053197.SGD","BK4588","IE00BLSP4452.SGD","LU0456855351.SGD","LU0321505439.SGD","LU0289739699.SGD","PFE","LU0868494617.USD","SG9999001176.USD","BK4599","LU1883839398.USD","IE0002270589.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU1023059063.AUD","LU1894683264.USD","BK4585","LU0122379950.USD","BK4550","BK4581","LU0058720904.USD","LU0306806265.USD","LU0306807586.USD","SG9999001176.SGD","LU0321505868.SGD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4534","SG9999003800.SGD","LU0234572021.USD","LU0170899867.USD","LU1894683348.USD","SG9999002224.SGD","LU1057294990.SGD","BK4592","LU1066051498.USD","BK4007","SG9999002232.USD","SG9999013999.USD","SGXZ57979304.SGD","BK4568","SG9999011175.SGD","LU0225284248.USD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2531747910","title":"21健讯Daily | 接棒吴以芳，陈玉卿出任复星医药董事长；阿斯利康一季度收入135.88亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531747910","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531747910?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 09:33","pubTimestamp":1745976806,"startTime":"0","endTime":"0","summary":"政策动向海南：促进仿制药质量提升支持首仿品种加快注册上市4月29日，《海南省全面深化药品医疗器械化妆品监管改革促进医药产业高质量发展实施方案》对外发布。其中提出，促进仿制药质量提升。一是支持首仿品种加快注册上市。对首仿品种实施专人负责、主动对接、加强指导、全程服务，在审评审批、注册核查、产品检验等方面给予支持。二是加强委托生产监管。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504303394003434.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504303394003434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1829250122.USD","BK1593","BK4568","LU2417539215.USD","BK1515","LU2236285917.USD","LU2456880835.USD","LU2462157665.USD","LU0109394709.USD","BK4007","BK4585","02196","LU0320765992.SGD","AZN","LU0889565916.HKD","BK1191","BK4588"],"gpt_icon":0},{"id":"2531424787","title":"阿斯利康在华面临800万美元新罚款？公司回应了","url":"https://stock-news.laohu8.com/highlight/detail?id=2531424787","media":"21世纪经济报道","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531424787?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 09:25","pubTimestamp":1745976323,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛上海报道有最新市场消息称，4月29日，阿斯利康在最新季度的财报会议上透露，该公司可能会在中国面临一项新的罚款，金额达800万美元。意见书显示，阿斯利康涉嫌偷逃进口税款，金额达160余万美元。若阿斯利康被最终判定需承担法律责任，可能被处以未缴进口税款一至五倍的罚金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043009352594e838a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043009352594e838a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU2462157665.USD","LU2417539215.USD","BK4568","LU0109394709.USD","BK4585","LU2236285917.USD","BK4007","LU2456880835.USD","AZN","LU0320765992.SGD","BK4588","LU1829250122.USD"],"gpt_icon":0},{"id":"2531420742","title":"阿斯利康4月29日成交额为5.64亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531420742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531420742?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 09:16","pubTimestamp":1745975817,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，阿斯利康成交额为5.64亿美元，成交额较昨日增加0.18%，当日成交量为791.91万股。阿斯利康于2025年4月29日涨2.55%，报71.71美元，该股过去5个交易日涨5.66%，年初至今涨11.23%，过去60日涨2.87%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|5.64亿|0.18%|791.91万|#|2025-04-28|5.63亿|21.81%|802.34万|#|2025-04-25|4.62亿|94.02%|666.27万|#|2025-04-24|2.38亿|-38.92%|343.21万|#|2025-04-23|3.90亿|-1.09%|567.40万|1999 年，瑞典阿斯特拉公司与英国捷利康集团合并，成立了阿斯利康公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091702a46cea66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091702a46cea66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2236285917.USD","LU0320765992.SGD","LU1829250122.USD","BK4007","BK4585","AZN","LU0109394709.USD","LU2417539215.USD","LU0889565916.HKD","LU2462157665.USD","BK4588","BK4568","LU2456880835.USD"],"gpt_icon":0},{"id":"2531740951","title":"雅培4月29日成交额为5.63亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531740951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531740951?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 09:15","pubTimestamp":1745975716,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，雅培成交额为5.63亿美元，成交额较昨日增加13.22%，当日成交量为431.53万股。雅培于2025年4月29日涨0.75%，报130.5美元，该股过去5个交易日跌0.93%，年初至今涨16.51%，过去60日涨2.48%。雅培约 60% 的销售额来自美国以外地区。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091531a6ce1135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430091531a6ce1135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1721429741.USD","LU0868494617.USD","LU0170899867.USD","IE00BFTCPJ56.SGD","BK4504","LU1023059063.AUD","BK4592","ABT","BK4588","BK4585","LU0266013472.USD","LU2112291526.USD","LU2237957811.SGD","LU2133065610.SGD","LU2089984988.USD","LU1721429402.USD","LU1057294990.SGD","SG9999002224.SGD","IE00BJT1NW94.SGD","LU2237957902.USD","SG9999004303.SGD","LU1061106388.HKD","BK4581","LU1989763427.SGD","LU2468319806.SGD","LU1691799644.USD","BK4566","IE00B2B36J28.USD","LU1989763690.USD","BK4533","IE0002141913.USD","IE00B4R5TH58.HKD","SG9999002232.USD","BK4082","IE0009355771.USD","LU0234572021.USD","SGXZ23171101.USD","LU1914381329.SGD","LU0122379950.USD","BK4568","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2531749214","title":"【吉利德科学与美国政府达成2亿美元和解协议】吉利德科学与美国政府达成2.02亿美元的和解协议，以解决其向医生支付费用并为他们提供活动餐费和差旅费以让其开出其药物的指控。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。该等活动原本纯粹是为了教育目的，并提供简单的餐点，但该公司在高档餐厅举办活动。检察官称，许多医生随后开出该公司的药物，迫使联邦医疗保健计划为该等处方支付数百万美元的报销费用。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531749214","media":"金融界","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531749214?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 09:07","pubTimestamp":1745975247,"startTime":"0","endTime":"0","summary":"吉利德科学与美国政府达成2.02亿美元的和解协议，以解决其向医生支付费用并为他们提供活动餐费和差旅费以让其开出其药物的指控。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。该等活动原本纯粹是为了教育目的，并提供简单的餐点，但该公司在高档餐厅举办活动。检察官称，许多医生随后开出该公司的药物，迫使联邦医疗保健计划为该等处方支付数百万美元的报销费用。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/30090750029382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE0002270589.USD","IE00B7SZLL34.SGD","LU1839511570.USD","LU0109394709.USD","LU0889565916.HKD","IE00B19Z3581.USD","BK4550","BK4588","IE00BKVL7J92.USD","BK4566","LU0058720904.USD","LU2087621335.USD","IE00B3T34201.USD","LU1066051498.USD","GILD","BK4578","LU2468319806.SGD","LU0289739699.SGD","BK4139","LU1571399168.USD","LU1585245621.USD","LU1066053197.SGD","BK4532","LU0320765992.SGD","BK4568","IE00BZ1G4Q59.USD","LU2089984988.USD","LU0234570918.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1430594728.SGD","BK4583","BK4585"],"gpt_icon":0},{"id":"2531514749","title":"阿斯利康在中国或面临800万美元新罚款，涉及乳腺癌药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2531514749","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531514749?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 09:03","pubTimestamp":1745975004,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0109394709.USD","LU2417539215.USD","LU2456880835.USD","AZN","BK4588","LU1829250122.USD","LU2236285917.USD","LU2462157665.USD","BK4007","LU0320765992.SGD","BK4568","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531727623","title":"多款 FIC 生物新药首发 AACR ！来自阿斯利康、GSK、信达...","url":"https://stock-news.laohu8.com/highlight/detail?id=2531727623","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531727623?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 08:43","pubTimestamp":1745973788,"startTime":"0","endTime":"0","summary":"2025 年 AACR 火热进行中。这次大会上，差不多有 50 款 FIC 生物新药首发亮相。据说今年这款产品就要启动首次人体临床试验了。GSK 和默克也不甘示弱，各自带来了一款 FIC 新药。信达是最多的，一口气公布了 4 款 FIC 新药，既有双抗、三抗，也有双抗 ADC和抗体类融合蛋白，药物类型特别丰富。另外，东阳光、菲鹏、辐联、启德、橙帆、塔吉瑞等十来家药企，也都在大会上展示了自家的 FIC 新药。最后，想要 2025 年 AACR 会议首发 FIC 新药清单的朋友，记得截图保存哦。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430121359a46d2035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430121359a46d2035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","LU1829250122.USD","BK4532","AZN","GSK","BK4585","GSK.UK","LU2236285917.USD","LU2462157665.USD","BK4588","LU0320765992.SGD","LU2456880835.USD","LU0889565916.HKD","LU0109394709.USD","LU2417539215.USD","BK4007"],"gpt_icon":0},{"id":"2531638715","title":"阿斯利康在中国或面临800万美元新罚款，涉及乳腺癌药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2531638715","media":"第一财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531638715?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 05:45","pubTimestamp":1745963100,"startTime":"0","endTime":"0","summary":"　　英国当地时间4月29日，阿斯利康在最新季度的财报会议上透露，该公司可能会在中国面临一项新的罚款，金额达800万美元。　　阿斯利康表示，最新的罚款涉嫌进口乳腺癌药物Enhertu的未缴纳税款。该公司在上一季度财报会上称，因另外两款抗癌药物Imfinzi和Imjudo未缴税款，将面临最高450万美元的罚款。去年10月底，阿斯利康前中国总裁王磊因涉嫌走私被带走。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-04-30/doc-ineuwute0399914.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-30/doc-ineuwute0399914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AZN","BK4007","BK4568","LU1829250122.USD","LU0889565916.HKD","LU2456880835.USD","LU2417539215.USD","LU2462157665.USD","LU0109394709.USD","LU0320765992.SGD","BK4585","LU2236285917.USD","BK4588"],"gpt_icon":0},{"id":"2531760523","title":"吉利德科学公司在美国就艾滋病药物回扣问题达成和解，将支付 2.02 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531760523","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531760523?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 02:31","pubTimestamp":1745951487,"startTime":"0","endTime":"0","summary":"更新版 1-吉利德科学公司在美国就艾滋病药物回扣问题达成和解，将支付 2.02 亿美元改写第一段；添加吉利德公司和美国律师的评论、指控、举报人详情、财务影响、署名Jonathan Stempel. 路透纽约4月29日 - 吉利德科学公司同意支付2.02亿美元，以了结一起举报人诉讼，该诉讼指控吉利德向同意开具其艾滋病药物处方的医生支付回扣，涉嫌民事欺诈。2024 年，吉利德的艾滋病药物销售总额达 196.1 亿美元，同比增长 8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4T3R728V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1571399168.USD","LU2087621335.USD","BK4585","LU1585245621.USD","BK4578","IE00B19Z3581.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","LU0234570918.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","GILD","BK4532","LU2089984988.USD","LU0109394709.USD","LU0889565916.HKD","BK4139","IE00B7SZLL34.SGD","BK4583","LU1430594728.SGD","LU1066051498.USD","BK4568","LU1066053197.SGD","LU1839511570.USD","BK4588","LU0320765992.SGD","LU2468319806.SGD","IE00BKVL7J92.USD","BK4550","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2531762855","title":"阿斯利康盘中异动 下午盘股价大涨3.02%报72.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531762855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531762855?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 01:40","pubTimestamp":1745948447,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日01时40分，阿斯利康股票出现波动，股价大幅拉升3.02%。截至发稿，该股报72.05美元/股，成交量543.799万股，换手率0.18%，振幅3.30%。阿斯利康股票所在的制药行业中，整体涨幅为1.44%。该信息摘要如下：阿斯利康公布的2025年第一季度利润超出预期，并重申其全年业绩指引。财报显示，阿斯利康一季度总营收135.9亿美元，不及市场预期；核心每股收益为 2.49 美元，同比增长21%，超过分析师预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430014047a6cda7e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430014047a6cda7e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2236285917.USD","LU0320765992.SGD","LU1829250122.USD","BK4007","BK4585","AZN","LU0109394709.USD","LU2417539215.USD","LU0889565916.HKD","LU2462157665.USD","BK4588","BK4568","LU2456880835.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":190,"code":"91000000","status":"200"}]}}